Cargando…
Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials
As a common disorder that accounts for over 70% of all breast disease cases, mammary gland hyperplasia (MGH) causes a severe problem for the quality of patients' life, and confers an increased risk of breast carcinoma. However, the etiology and pathogenesis of MGH remain unclear, and the safety...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801403/ https://www.ncbi.nlm.nih.gov/pubmed/29456506 http://dx.doi.org/10.3389/fphar.2018.00045 |
_version_ | 1783298342633078784 |
---|---|
author | Li, Hao-Tian Liu, Hong-Hong Yang, Yu-Xue Wang, Tao Zhou, Xue-Lin Yu, Yang Li, Su-Na Zheng, Yi Zhang, Ping Wang, Rui-Lin Li, Jian-Yu Wei, Shi-Zhang Li, Kun Li, Peng-Yan Qian, Li-Qi |
author_facet | Li, Hao-Tian Liu, Hong-Hong Yang, Yu-Xue Wang, Tao Zhou, Xue-Lin Yu, Yang Li, Su-Na Zheng, Yi Zhang, Ping Wang, Rui-Lin Li, Jian-Yu Wei, Shi-Zhang Li, Kun Li, Peng-Yan Qian, Li-Qi |
author_sort | Li, Hao-Tian |
collection | PubMed |
description | As a common disorder that accounts for over 70% of all breast disease cases, mammary gland hyperplasia (MGH) causes a severe problem for the quality of patients' life, and confers an increased risk of breast carcinoma. However, the etiology and pathogenesis of MGH remain unclear, and the safety and efficacy of current western drug therapy for MGH still need to be improved. Therefore, a meta-analysis was conducted by our team to determine whether a TCM formula named Ru-Pi-Xiao in combination with tamoxifen or Ru-Pi-Xiao treated alone can show more prominent therapeutic effects against MGH with fewer adverse reactions than that of tamoxifen. Studies published before June 2017 were searched based on standardized searching rules in several mainstream medical databases. A total of 27 articles with 4,368 patients were enrolled in this meta-analysis. The results showed that the combination of Ru-Pi-Xiao and tamoxifen could exhibit better therapeutic effects against MGH than that of tamoxifen (OR: 3.79; 95% CI: 3.09–4.65; P < 0.00001) with a lower incidence of adverse reactions (OR: 0.35; 95% CI: 0.28–0.43; P < 0.00001). The results also suggested that this combination could improve the level of progesterone (MD: 2.22; 95% CI: 1.72–2.71; P < 0.00001) and decrease the size of breast lump (MD: −0.67; 95% CI: −0.86 to −0.49; P < 0.00001) to a greater extent, which might provide a possible explanation for the pharmacodynamic mechanism of Ru-Pi-Xiao plus tamoxifen. In conclusion, Ru-Pi-Xiao and related preparations could be recommended as auxiliary therapy combined tamoxifen for the treatment of MGH. |
format | Online Article Text |
id | pubmed-5801403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58014032018-02-16 Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials Li, Hao-Tian Liu, Hong-Hong Yang, Yu-Xue Wang, Tao Zhou, Xue-Lin Yu, Yang Li, Su-Na Zheng, Yi Zhang, Ping Wang, Rui-Lin Li, Jian-Yu Wei, Shi-Zhang Li, Kun Li, Peng-Yan Qian, Li-Qi Front Pharmacol Pharmacology As a common disorder that accounts for over 70% of all breast disease cases, mammary gland hyperplasia (MGH) causes a severe problem for the quality of patients' life, and confers an increased risk of breast carcinoma. However, the etiology and pathogenesis of MGH remain unclear, and the safety and efficacy of current western drug therapy for MGH still need to be improved. Therefore, a meta-analysis was conducted by our team to determine whether a TCM formula named Ru-Pi-Xiao in combination with tamoxifen or Ru-Pi-Xiao treated alone can show more prominent therapeutic effects against MGH with fewer adverse reactions than that of tamoxifen. Studies published before June 2017 were searched based on standardized searching rules in several mainstream medical databases. A total of 27 articles with 4,368 patients were enrolled in this meta-analysis. The results showed that the combination of Ru-Pi-Xiao and tamoxifen could exhibit better therapeutic effects against MGH than that of tamoxifen (OR: 3.79; 95% CI: 3.09–4.65; P < 0.00001) with a lower incidence of adverse reactions (OR: 0.35; 95% CI: 0.28–0.43; P < 0.00001). The results also suggested that this combination could improve the level of progesterone (MD: 2.22; 95% CI: 1.72–2.71; P < 0.00001) and decrease the size of breast lump (MD: −0.67; 95% CI: −0.86 to −0.49; P < 0.00001) to a greater extent, which might provide a possible explanation for the pharmacodynamic mechanism of Ru-Pi-Xiao plus tamoxifen. In conclusion, Ru-Pi-Xiao and related preparations could be recommended as auxiliary therapy combined tamoxifen for the treatment of MGH. Frontiers Media S.A. 2018-02-02 /pmc/articles/PMC5801403/ /pubmed/29456506 http://dx.doi.org/10.3389/fphar.2018.00045 Text en Copyright © 2018 Li, Liu, Yang, Wang, Zhou, Yu, Li, Zheng, Zhang, Wang, Li, Wei, Li, Li and Qian. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Hao-Tian Liu, Hong-Hong Yang, Yu-Xue Wang, Tao Zhou, Xue-Lin Yu, Yang Li, Su-Na Zheng, Yi Zhang, Ping Wang, Rui-Lin Li, Jian-Yu Wei, Shi-Zhang Li, Kun Li, Peng-Yan Qian, Li-Qi Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials |
title | Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials |
title_full | Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials |
title_fullStr | Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials |
title_full_unstemmed | Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials |
title_short | Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials |
title_sort | therapeutic effects of a traditional chinese medicine formula plus tamoxifen vs. tamoxifen for the treatment of mammary gland hyperplasia: a meta-analysis of randomized trials |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801403/ https://www.ncbi.nlm.nih.gov/pubmed/29456506 http://dx.doi.org/10.3389/fphar.2018.00045 |
work_keys_str_mv | AT lihaotian therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT liuhonghong therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT yangyuxue therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT wangtao therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT zhouxuelin therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT yuyang therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT lisuna therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT zhengyi therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT zhangping therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT wangruilin therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT lijianyu therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT weishizhang therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT likun therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT lipengyan therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials AT qianliqi therapeuticeffectsofatraditionalchinesemedicineformulaplustamoxifenvstamoxifenforthetreatmentofmammaryglandhyperplasiaametaanalysisofrandomizedtrials |